No data pointing to CYP-interactions.

(To be edited, initial data ST OCT 04) Butylsulfonyl phenyalanine platelet inhibitor. Given together with ASA and heparin as intravenous infusion 0.4 ug/kg BW/ min to prevent early infarction in instable angina and other cardiac conditions.